Most articles about stem cell injections are written to sell them. This one is not. If you are considering treatment, you deserve a clear account of what can go wrong, what the procedure cannot do, and which patients should not have it at all. A clinic that will not tell you these things is not protecting you from worry. It is protecting itself from scrutiny.
This article covers medical risk and realistic expectations only. For the legal and regulatory side, see stem cell treatment regulations in Mexico. For comparing providers, see how to choose a stem cell clinic in Mexico.
What a Stem Cell Injection Involves
A stem cell injection delivers cells into or near a target tissue, most often a joint, tendon, or spinal structure, with the intention of supporting the body own repair and modulating inflammation. The cells may come from the patient, usually bone marrow or adipose tissue, or from donated perinatal tissue such as umbilical cord. Delivery may be image guided, placed directly into a joint, or given intravenously depending on the protocol.
It is a medical procedure. Like every medical procedure, it carries risk, and like every medical procedure, that risk is worth weighing against the alternative, which for many patients is continued pain, long-term anti-inflammatory use, or surgery.
Known Risks and Side Effects
Injection Site Reactions
The most common effects are the mildest. Pain, swelling, stiffness, bruising, and a temporary flare of symptoms at the treated site are reported frequently and usually settle within several days to two weeks. A short-term increase in pain after an injection is common enough that patients should be warned about it in advance rather than alarmed by it afterward.
Infection
Any injection breaks the skin barrier and introduces a route for infection. Joint infection is uncommon but serious, and it is the risk most directly controlled by sterile technique, facility standards, and proper handling of the cell preparation. Fever, escalating pain, heat, or spreading redness after a procedure is not something to wait out. It is a reason to seek medical attention the same day.
Immune and Allergic Reactions
Donor-derived cells carry a theoretical risk of immune reaction, and preparations containing additives or carrier solutions can provoke allergic responses in sensitive patients. Reported reactions in this setting are typically mild, but patients with known allergies should disclose them during evaluation rather than at the appointment.
Rare but Serious Complications
Published case reports across the wider industry include blood clots following intravenous administration, cell growth in unintended locations, and vision damage after injections near the eye. These are rare and several are associated with procedures well outside mainstream protocols. They are also real, documented, and the reason that where and by whom a procedure is performed is not a secondary question.

Limitations: What Stem Cell Therapy Cannot Do
Results Vary and Are Not Guaranteed
Some patients report meaningful improvement in pain and function. Some report modest improvement. Some report none. This is the honest distribution, and anyone presenting a single success rate across different conditions, severities, and ages is quoting a marketing number rather than a clinical one.
It Is Not a Replacement for Conventional Care
Stem cell therapy does not treat infection, does not treat cancer, and does not replace medication for a condition that requires it. Patients should not stop prescribed treatment in anticipation of a regenerative procedure, and no responsible clinic will suggest otherwise.
Advanced Structural Damage May Not Respond
Cell therapy works with biology, not architecture. A joint with bone-on-bone contact, a fully ruptured tendon, or significant mechanical instability presents a structural problem, and expecting an injection to rebuild that structure sets up disappointment. Earlier-stage degeneration generally offers more room for a biological intervention to matter.
Effects May Be Temporary
Where improvement occurs, it may be partial, and it may fade over months or years. Some patients choose repeat treatment. That is a legitimate decision, but it should be a decision made with the cost and the uncertainty in full view from the beginning.
Who Should Not Have Stem Cell Injections
Candidacy is determined by a physician who has reviewed your history and imaging, but treatment is generally not appropriate for patients with an active infection, an active or recently treated cancer, certain blood disorders, uncontrolled systemic illness, or pregnancy. If a provider is willing to schedule you without knowing these things, that is the clearest warning you will get.
Red Flags in Treatment Marketing
- A guaranteed outcome. No legitimate provider guarantees a medical result.
- A cure claim. Particularly for conditions with no known cure.
- A price before an evaluation. A quote that precedes any review of your case is a sales step, not a medical one.
- Pressure to decide quickly. Expiring discounts belong in retail.
- Vagueness about cell source. You are entitled to know exactly what is being injected into you.
- No answer on complications. Ask what happens if something goes wrong after you fly home. The quality of that answer tells you most of what you need.
Questions to Ask Before You Consent
What specifically is being injected, and where does it come from? What outcome is realistic for my diagnosis and stage? What are the odds this does nothing? What complications has this clinic seen, and how were they handled? Who manages my care if I have a problem after discharge? What is the follow-up schedule, and is it included?
A provider who answers these directly, including the uncomfortable ones, is demonstrating the thing you are actually trying to assess.
Final Thoughts
Stem cell injections are not inherently dangerous, and they are not a miracle. For the right patient with the right diagnosis and realistic expectations, they are a reasonable option with a modest risk profile. For the wrong patient, or for a patient who has been sold certainty, they are an expensive disappointment at best.
The patients who do best are the ones who went in knowing exactly what they were buying. At Regenamex, treatment is scheduled only after a physician evaluation, and we will tell you if we do not think you are a good candidate. You can request an evaluation here.
Pain, swelling, stiffness, bruising, and a temporary flare of symptoms at the injection site are the most frequently reported effects. These are usually mild and typically settle within several days to two weeks. A short-term increase in pain after the procedure is common and should be explained to you in advance.
For appropriately screened patients treated in a licensed facility using sterile technique, the risk profile is generally modest, with mild local reactions being most common. The serious risks are infection, immune reaction, and rare complications documented in case reports. Safety depends heavily on patient selection, cell handling, and where the procedure is performed.
Permanent worsening is uncommon, but it is not impossible. Joint infection, which is rare but serious, can cause lasting damage. A temporary increase in pain for a few days is far more common and is not the same thing. Fever, escalating pain, heat, or spreading redness after treatment warrants same-day medical attention.
Treatment is generally not appropriate for patients with an active infection, an active or recently treated cancer, certain blood disorders, uncontrolled systemic illness, or pregnancy. Candidacy should be determined by a physician who has reviewed your history and imaging, not by an intake form.
Outcomes vary widely. Some patients report meaningful improvement in pain and function, some report modest improvement, and some report none. Results depend on diagnosis, severity, age, and overall health. Any provider quoting a single success rate across different conditions is giving you a marketing figure, not a clinical one.
Where improvement occurs it may be partial and may fade over months or years. Some patients elect repeat treatment. The cost and the uncertainty of that possibility should be clear to you before the first procedure, not after it.